Leuplinforection and cerebral haemorrhage Patient Reports February 11, 2012
Leuplinforection Side Effects Report #5214756-1
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Jan 12, 2007. Male patient, 86 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, granuloma skin, herpes zoster, hot flush, injection site induration, injection site nodule. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, HARNAL D. Patient was hospitalized. Patient died.
Leuplinforection Side Effects Report #5179081-6
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Dec 05, 2006. Male patient, 86 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, injection site abscess, injection site induration, neoplasm skin, urinary tract infection
. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 1 12 WK). During the same period patient was treated with CASODEX, HARNAL. Patient died.Leuplinforection Side Effects Report #6093708-6
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Feb 19, 2009. Male patient, 80 years of age, was diagnosed with prostate cancer stage iv, benign prostatic hyperplasia and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: cerebral haemorrhage. Leuplinforection dosage: unknown. During the same period patient was treated with CASODEX, HARNAL. Patient died on 04/20/2008.
Leuplinforection Side Effects Report #6136361-5
Leuplinforection side effect was reported by a Health Professional from JAPAN on Mar 19, 2009. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, hypertension. Leuplinforection dosage: unknown. During the same period patient was treated with CASODEX. Patient was hospitalized. Patient recovered.
Leuplinforection and cerebral haemorrhage 